 Connection
Yan Li to Vitamins
This is a "connection" page, showing publications Yan Li has written about Vitamins.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.612 |
|
|
|
-
Deb DK, Sun T, Wong KE, Zhang Z, Ning G, Zhang Y, Kong J, Shi H, Chang A, Li YC. Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. Kidney Int. 2010 Jun; 77(11):1000-9.
Score: 0.397
-
Zhang Y, Deb DK, Kong J, Ning G, Wang Y, Li G, Chen Y, Zhang Z, Strugnell S, Sabbagh Y, Arbeeny C, Li YC. Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Am J Physiol Renal Physiol. 2009 Sep; 297(3):F791-801.
Score: 0.378
-
Li YC. Renoprotective effects of vitamin D analogs. Kidney Int. 2010 Jul; 78(2):134-9.
Score: 0.377
-
Deb DK, Chen Y, Zhang Z, Zhang Y, Szeto FL, Wong KE, Kong J, Li YC. 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway. Am J Physiol Renal Physiol. 2009 May; 296(5):F1212-8.
Score: 0.369
-
Li YC. Vitamin D and diabetic nephropathy. Curr Diab Rep. 2008 Dec; 8(6):464-9.
Score: 0.091
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|